iridex corp (IRIX) Key Developments
IRIDEX Corporation Announces Preliminary Unaudited Revenues for the Fourth Quarter and Full Year 2014; Provides Revenue Outlook for Fiscal Year 2015
Jan 12 15
IRIDEX Corporation announced preliminary unaudited revenues for the fourth quarter and full year 2014. For the quarter, the company’s revenue was $11.5 to $11.7 million.
For the year, the company’s revenue was $42.5 to $42.7 million.
For the fiscal 2015, the company currently expects to generate revenues of between $48 million and $51 million.
IRIDEX Corporation Announces Board Changes
Dec 31 14
IRIDEX Corporation announced that it has appointed ophthalmology and medical laser executive George R. Marcellino, Ph.D., to its Board of Directors, effective immediately. Dr. Marcellino is a co-founder of Sunnyvale, CA-based OptiMedica Corporation, and he fills the seat vacated by James B. Hawkins, who is rotating off the Board after 7 years of service to the IRIDEX shareholders. He currently serves as vice president of clinical sciences and global advocacy. Prior to OptiMedica, from 1988 to 2003, Dr. Marcellino held senior research, sales and marketing roles at Santa Clara, CA-based Coherent, Inc, and its subsequent embodiment Lumenis Ltd. His prior medical and laser experience includes management and director level roles at Laserscope Inc., Cooper Laseronics Inc. and Oximetrix all located in the San Francisco Bay area.
IRIDEX Secures Large Ophthalmology Laser Equipment Tender to Supply Rural Chinese Regions
Dec 2 14
IRIDEX Corporation announced that its China distributor has been awarded a competitive tender for more than $620,000 in ophthalmology laser equipment to fulfill a government program designed to provide advanced ophthalmology solutions to patients across vast areas of China's rural regions. Moore added that the advances in laser-based therapies are also ushering in a paradigm shift in the U.S. and European ophthalmology markets, including diabetic macular edema (DME) and glaucoma treatments.
IRIDEX Corporation Secures Large Tender from Government of Zambia for Ophthalmology Laser Equipment
Nov 19 14
IRIDEX Corporation announced that it has been awarded a competitive tender for more than $350,000 in ophthalmology laser equipment by the government of Zambia.
IRIDEX Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 27, 2014; Provides Earnings Guidance for the Fourth Quarter of 2014
Oct 30 14
IRIDEX Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended September 27, 2014. For the quarter, the company reported net income of $490,000 or $0.05 per basic and diluted share on total revenues of $10,118,000 compared to net income of $530,000 or $0.05 per basic and diluted share on total revenues of $9,526,000 a year ago. Income from operations was $606,000 against $665,000 a year ago. Income from continuing operations before provision for income taxes was $494,000 against $580,000 a year ago.
For the nine months, the company reported net income of $1,274,000 or $0.12 per diluted share on total revenues of $31,036,000 compared to net income of $1,819,000 or $0.18 per basic and diluted share on total revenues of $27,675,000 a year ago. Income from operations was $1,603,000 against $2,077,000 a year ago. Income from continuing operations before provision for income taxes was $1,303,000 against $1,877,000 a year ago.
For the fourth quarter, the company expects to achieve revenue of $10.9 million to $11.2 million, which compares to revenues of $10.6 million for the 2013 fourth quarter. Gross margin is anticipated to come in between 49% and 51%, and operating expenses are expected to be $4.7 million to $4.9 million.